Scott M. Coiante - 03 Oct 2023 Form 4 Insider Report for AGILE THERAPEUTICS INC (AGRX)

Role
Chief Financial Officer
Signature
/s/ Geoffrey P. Gilmore Attorney-in-Fact
Issuer symbol
AGRX
Transactions as of
03 Oct 2023
Net transactions value
$0
Form type
4
Filing time
04 Oct 2023, 16:45:13 UTC
Previous filing
25 Aug 2023
Next filing
26 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGRX Common Stock Award $0 +20,000 +25000% $0.000000 20,080 03 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") which were granted as an inducement grant to a new hire on October 3, 2023. The RSUs will vest in four equal installments over four years with the first installment vesting on August 16, 2024 and with the RSUs being fully vested on August 16, 2027.